Physician profile
Steve Georgopoulos
NPI 1043371487
$251.17
in general payments reported to CMS, 2019-2025
11 companies · $42.71 in 2025
The $42.71 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.51 · 2021: $50.18 · 2022: $80.71 · 2023: $43.92 · 2024: $13.14 · 2025: $42.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $70.69 | 2019-2021 | |
| Glaxosmithkline, LLC. | $25.75 | 2022 | |
| Amgen INC. | $23.67 | 2025 | Evenity |
| Redhill Biopharma INC. | $22.08 | 2022 | |
| Daiichi Sankyo INC. | $20.63 | 2022 | |
| Exact Sciences Corporation | $19.04 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.82 | 2023 | Dificid |
| Janssen Pharmaceuticals, INC | $14.56 | 2023 | Xarelto |
| Corcept Therapeutics | $14.54 | 2023 | Korlym |
| Micro-Tech Endoscopy USA, INC. | $13.14 | 2024 | Suretrac |
| Takeda Pharmaceuticals U.S.A., INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Georgopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.